Literature DB >> 15308621

Crystal structures of the phosphorylated and unphosphorylated kinase domains of the Cdc42-associated tyrosine kinase ACK1.

Julie C Lougheed1, Rui-Hong Chen, Polly Mak, Thomas J Stout.   

Abstract

ACK1 is a multidomain non-receptor tyrosine kinase that is an effector of the Cdc42 GTPase. Members of the ACK family have a unique domain ordering and are the only tyrosine kinases known to interact with Cdc42. In contrast with many protein kinases, ACK1 has only a modest increase in activity upon phosphorylation. We have solved the crystal structures of the human ACK1 kinase domain in both the unphosphorylated and phosphorylated states. Comparison of these structures reveals that ACK1 adopts an activated conformation independent of phosphorylation. Furthermore, the unphosphorylated activation loop is structured, and its conformation resembles that seen in activated tyrosine kinases. In addition to the apo structure, complexes are also presented with a non-hydrolyzable nucleotide analog (adenosine 5'-(beta,gamma-methylenetriphosphate)) and with the natural product debromohymenialdisine, a general inhibitor of many protein kinases. Analysis of these structures reveals a typical kinase fold, a pre-organization into the activated conformation, and an unusual substrate-binding cleft.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308621     DOI: 10.1074/jbc.M406703200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Structure-function correlation of G6, a novel small molecule inhibitor of Jak2: indispensability of the stilbenoid core.

Authors:  Anurima Majumder; Lakshmanan Govindasamy; Andrew Magis; Róbert Kiss; Tímea Polgár; Rebekah Baskin; Robert W Allan; Mavis Agbandje-McKenna; Gary W Reuther; György M Keseru; Kirpal S Bisht; Peter P Sayeski
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

2.  Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange.

Authors:  Antony W Oliver; Angela Paul; Katherine J Boxall; S Elaine Barrie; G Wynne Aherne; Michelle D Garrett; Sibylle Mittnacht; Laurence H Pearl
Journal:  EMBO J       Date:  2006-06-22       Impact factor: 11.598

3.  Conserved tyrosine kinase promotes the import of silencing RNA into Caenorhabditis elegans cells.

Authors:  Antony M Jose; Yunsoo A Kim; Steven Leal-Ekman; Craig P Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-21       Impact factor: 11.205

Review 4.  Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

5.  Cancer-associated mutations activate the nonreceptor tyrosine kinase Ack1.

Authors:  Victoria Prieto-Echagüe; Azad Gucwa; Barbara P Craddock; Deborah A Brown; W Todd Miller
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

6.  High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.

Authors:  Chandrasekhar V Miduturu; Xianming Deng; Nicholas Kwiatkowski; Wannian Yang; Laurent Brault; Panagis Filippakopoulos; Eunah Chung; Qingkai Yang; Juerg Schwaller; Stefan Knapp; Randall W King; Jiing-Dwan Lee; Sanna Herrgard; Patrick Zarrinkar; Nathanael S Gray
Journal:  Chem Biol       Date:  2011-07-29

7.  Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.

Authors:  Wing Chan; Rui Tian; Yeow-Fong Lee; Soon Tuck Sit; Louis Lim; Ed Manser
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

8.  The human kinome and kinase inhibition.

Authors:  Krisna C Duong-Ly; Jeffrey R Peterson
Journal:  Curr Protoc Pharmacol       Date:  2013-03

9.  Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase.

Authors:  Elham Behshad; Ronald M Klabe; Alexander Margulis; Mary Becker-Pasha; Mark J Rupar; Paul Collier; Phillip C Liu; Gregory F Hollis; Timothy C Burn; Richard Wynn
Journal:  Curr Chem Genomics       Date:  2010-04-23

Review 10.  ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Cancer Lett       Date:  2013-04-15       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.